Muscle & Nerve · 2000 · 104 citations · 22 references
MedicinePharmacologyPharmacotherapyNeurodegenerationNeuromuscular DisordersPathophysiologyCalcineurin InhibitorsMuscle DisordersMuscle PathologyMuscle PhysiologyMuscular DystrophyCalpain ActivityCalpain SystemDuchenne Muscular Dystrophy PharmacotherapyDystrophin DeficiencyHistologic ExaminationMuscle Fiber DegenerationMuscular Dystrophy PathophysiologySkeletal Muscle Degeneration
Inhibition of muscle degeneration by the tripeptide calpain inhibitor, leupeptin, was tested in vivo in a dystrophin-deficient mdx murine model. In a short-term control study, intramuscular administration of leupeptin for 30 days inhibited muscle degeneration as assessed by histologic analysis. Calpain inhibition could be correlated with retention of myofiber size and our results suggest that this may be a promising treatment modality in human Duchenne muscular dystrophy.
22
Dystrophin: The protein product of the duchenne muscular dystrophy locus
Eric P. Hoffman, Robert H. Brown, Louis M. Kunkel · Cell · 1987 · 4.7K citations
X chromosome-linked muscular dystrophy (mdx) in the mouse.
G. Bulfield, W. G. Siller, P.A.L. Wight et al. · Proceedings of the National Academy of Sciences · 1984 · 1.8K citations · Full text
Craig M. McDonald, Richard T. Abresch, Gregory T. Carter et al. · American Journal of Physical Medicine & Rehabilitation · 1995 · 1.1K citations
Paul R. Turner, Tim Westwood, Chester M. Regen et al. · Nature · 1988 · 456 citations
Medicine, Biochemistry, Physiology +16
Bahram Mokri, Andrew G. Engel · Neurology · 1975 · 449 citations
Medicine, Anatomy, Physiology +17